Medethix Incorporated Pharmaceutical Import Profile — Philippines (DGFT 2022–2026)

Name: Medethix Incorporated Pharmaceutical Import Records from India — 2 Products, $289.3K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Medethix Incorporated — Pharmaceutical Importer Profile (2026) | 2 Products, $289.3K Trade | TransData Nexus

Who Are the Verified Indian Suppliers to Medethix Incorporated?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Albert David Limited	$1.0M	43	55.0%
Concept Pharmaceuticals Limited	$244.2K	10	13.1%
Khandelwal Laboratories Private Limited	$183.1K	24	9.8%
Medopharm Private Limited	$101.2K	8	5.4%
Sydler Remedies Private Limited	$100.0K	2	5.4%
Aumgen Pharma Llp	$66.7K	4	3.6%
Stratgen Healthcare Private Limited	$50.0K	1	2.7%
Pelltech Healthcare Private Limited	$35.2K	5	1.9%
Bafna Pharmaceuticals Limited	$29.0K	1	1.6%
Pell Tech Health Care Private Limited	$26.4K	3	1.4%

Medethix Incorporated sources from 10 verified Indian suppliers across 80 distinct formulations. The supply base is diversified across 10 suppliers, reducing single-source dependency risk.

What Formulations Does Medethix Incorporated Import?

Formulation	Value	Ships
Tablets of tramadol hcl37.5	$50.0K	3
Medicaments lupibile (ursodeoxycholic	$50.0K	1
Lupibile ursodeoxycholic acid 300 MG TAB drug lic dl46mb valid 31 12 2027 batch no 3t76003 mfg 02 2023 exp 01	$50.0K	1
Lupibile ursodeoxycholic acid 300 MG TAB drug lic dl46mb valid 31 12 2027 batch no 3t76002 mfg 02 2023 exp 01	$50.0K	1
Dydrogest(dydrogesterone 10MG	$50.0K	1
Lupibile ursodeoxycholic acid 300 MG	$50.0K	1
Lupibile (ursodeoxycholic acid 300 MG TAB) drug lic-dl46mb valid 31.12.2027 (batch no-3t76005 mfg.08/2023 exp.07/2026)

What Products Does Medethix Incorporated Import?

Top Products by Import Value

1Ipratropium$243.1K 2Plasma$46.2K

Medethix Incorporated Therapeutic Categories — 2 Specializations

Medethix Incorporated imports across 2 therapeutic categories, with Respiratory (84.0%), Other (16.0%), representing the largest segments. The portfolio is concentrated — top 5 products = 100% of total imports.

Respiratory

1 products · 84.0% · $243.1K

Other

1 products · 16.0% · $46.2K

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ipratropium	Respiratory	$243.1K	5	0.4%	17
2	Plasma	Other	$46.2K	4	1.6%	9

Key Metrics

Total Import Value$289.3K

Products2

Shipments9

Categories2

CountryPhilippines

#1 Rankings0

Indian Suppliers10

Formulations80

Top Categories

Respiratory84.0%

Other16.0%

Indian Suppliers

Last updated: March 28, 2026

Medethix Incorporated — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

MedEthix Incorporated is a Philippine-based pharmaceutical company established in 2009, specializing in the sourcing, registration, importation, and distribution of healthcare products. Headquartered at 6/F RFM Corporate Center, Pioneer St, Mandaluyong City, 1550 Philippines, the company is committed to making quality healthcare solutions accessible and affordable to every Filipino. (medethix.com.ph)

In November 2019, MedEthix expanded its operations through a strategic partnership with Ayala Healthcare Holdings, Inc. (AC Health), a subsidiary of the Ayala Group. This collaboration aimed to strengthen the pharmaceutical supply chain in the Philippines, enhancing the availability of quality medicines across the country. (medethix.com.ph)

2Distribution Network

MedEthix's distribution network is strategically located in the National Capital Region (NCR), with warehouses situated in Pasay City. These facilities adhere to Good Warehousing Practice (GWP), ensuring consistent temperature monitoring and strict cold-chain controls to maintain product quality. The company's logistics capabilities are designed to meet international standards, facilitating efficient distribution throughout the Philippines. (medethix.com.ph)

Supplier Relationship Intelligence — Medethix Incorporated

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

MedEthix's sourcing strategy exhibits a high degree of concentration, with a portfolio comprising only two imported products across two therapeutic categories. The top five products—comprising Ipratropium and Plasma—account for 100% of the company's imports. This singular focus on a limited product range suggests a strategic choice to specialize in specific therapeutic areas, potentially allowing for deeper market penetration and expertise. However, such concentration also exposes the company to risks associated with supply chain disruptions or regulatory changes affecting these products.

2Supply Chain Resilience

MedEthix's supply chain resilience is bolstered by its partnerships with multiple Indian suppliers, including ALBERT DAVID LIMITED, CONCEPT PHARMACEUTICALS LIMITED, and KHANDELWAL LABORATORIES PRIVATE LIMITED. This diversified supplier base mitigates risks associated with single-source dependency. The company's adherence to stringent regulatory standards, such as obtaining over 500 product registrations from the Philippine FDA, underscores its commitment to quality and compliance. Additionally, the strategic location of its warehouses in Pasay City facilitates efficient logistics and distribution, enhancing supply chain robustness. (medethix.com.ph)

3Strategic Implications

MedEthix's concentrated sourcing strategy positions the company as a specialized player in the Philippine pharmaceutical market, potentially offering competitive advantages in terms of expertise and market focus. For Indian exporters, this presents an opportunity to establish strong partnerships by aligning with MedEthix's product focus and quality standards. Engaging with MedEthix could lead to increased market access and collaboration in the distribution of specific pharmaceutical products within the Philippines.

TransData Nexus Research · Verified DGFT customs dataMar 2026

Importing Pharmaceuticals into Philippines — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Philippines

1Regulatory Authority & Framework

The Philippine Food and Drug Administration (FDA) is the primary regulatory body overseeing pharmaceutical imports into the Philippines. Key legislation governing these imports includes the Food and Drug Administration Act of 2009 (Republic Act No. 9711), which outlines the regulatory framework for the importation, distribution, and marketing of pharmaceutical products. The marketing authorization pathway for Indian generics involves obtaining product registrations from the Philippine FDA, ensuring compliance with local standards and regulations. (medethix.com.ph)

2Import Licensing & GMP

Import licensing requirements in the Philippines mandate that pharmaceutical importers obtain product registrations from the Philippine FDA, demonstrating compliance with local standards. Good Manufacturing Practice (GMP) certificates from recognized authorities, such as the World Health Organization (WHO) or the Pharmaceutical Inspection Co-operation Scheme (PIC/S), are essential for ensuring product quality and safety. Wholesale distribution authorization is also required, allowing companies like MedEthix to distribute pharmaceutical products within the country. (medethix.com.ph)

3Quality & Labeling

Pharmaceutical products imported into the Philippines must undergo batch testing to ensure quality and safety. Stability requirements are enforced to guarantee that products maintain their efficacy throughout their shelf life. Labeling must be in English and Filipino, providing clear information on usage, dosage, and storage. Serialization mandates are implemented to enhance traceability and prevent counterfeit products from entering the market. (medethix.com.ph)

4Recent Regulatory Changes

Between 2024 and 2026, the Philippines implemented several regulatory changes affecting pharmaceutical imports. These include the signing of the Executive Order for Maximum Drug Retail Price (MDRP), aimed at making medicines more affordable, and the enactment of the Universal Health Care Act, which seeks to provide equitable access to quality health services. These policies are expected to influence the importation and distribution strategies of pharmaceutical companies operating in the Philippines. (medethix.com.ph)

TransData Nexus Research · Philippines regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Matching: Medethix Incorporated identified across shipments using consignee name normalization, aggregating 2 name variants.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
3.Market Share: Calculated per product as Medethix Incorporated's capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 9 individual customs records matching Medethix Incorporated.
5.Supplier Verification: Medethix Incorporated sources from 10 verified Indian suppliers across 80 formulations, confirmed from customs records.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2 Products Tracked

2 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Medethix Incorporated

Medethix Incorporated — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Medethix Incorporated?

What Formulations Does Medethix Incorporated Import?

What Products Does Medethix Incorporated Import?

Top Products by Import Value

Medethix Incorporated Therapeutic Categories — 2 Specializations

Import Portfolio — Top 2 by Import Value

Key Metrics

Top Categories

Indian Suppliers

Medethix Incorporated — Corporate Profile & Information

1Company Overview

2Distribution Network

Related Trade Data

Need Detailed Data?

3Industry Role

Supplier Relationship Intelligence — Medethix Incorporated

1Sourcing Concentration Analysis

2Supply Chain Resilience

3Strategic Implications

Importing Pharmaceuticals into Philippines — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

3Quality & Labeling

4Recent Regulatory Changes

Medethix Incorporated — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

3Market Positioning

Seller's Guide — How to Become a Supplier to Medethix Incorporated

1Opportunity Assessment

2Requirements & Qualifications

3How to Approach

Frequently Asked Questions — Medethix Incorporated

What products does Medethix Incorporated import from India?

Who supplies pharmaceuticals to Medethix Incorporated from India?

What is Medethix Incorporated's total pharmaceutical import value?

What therapeutic categories does Medethix Incorporated focus on?

Get Full Medethix Incorporated Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology